12 Health Care Stocks Moving In Tuesday's Intraday Session
Portfolio Pulse from Benzinga Insights
In Tuesday's intraday session, several healthcare stocks experienced significant movements. Monopar Therapeutics led the gainers with a 138.8% increase, while RAPT Therapeutics saw the largest decline at 66.2%. Other notable movers include Trxade Health, Biofrontera, Iovance Biotherapeutics, and SeaStar Medical Holding among the gainers, and Summit Therapeutics, Better Therapeutics, Universe Pharmaceuticals, Sientra, and Tenaya Therapeutics among the losers.
February 20, 2024 | 5:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
RAPT Therapeutics stock fell 66.2% to $8.77, with a market cap of $301.6 million.
The significant drop in RAPT Therapeutics' stock price could be due to negative news or market reactions, indicating a negative short-term outlook.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
Summit Therapeutics shares declined 26.34% to $3.73, with a market cap of $2.6 billion. Q4 earnings were released.
The decline in Summit Therapeutics' stock price following the Q4 earnings release suggests the market reacted negatively to the earnings report, indicating a short-term negative impact.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 90
POSITIVE IMPACT
Trxade Health shares increased 86.05% to $8.54, with a market value of $10.2 million.
The substantial rise in Trxade Health's stock price could reflect positive developments or investor optimism, suggesting a favorable short-term impact.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 90
POSITIVE IMPACT
Monopar Therapeutics shares surged 138.8% to $0.82, with a market value of $12.1 million.
The significant price surge indicates strong investor interest, potentially due to positive news or market sentiment, suggesting a positive short-term outlook.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100